Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Ottawa

$25,000.00

Systems biology of campylobacter jejuni and vaccine development

EF 2009-10

Résumé
C. jejuni is the leading cause of bacterial gastroenteritis worldwide and thus constitutes a major public health threat. Despite this high incidence, a clear picture of the processes involved in Campylobacter infection has not yet emerged, preventing the development of new therapeutics and prevention strategies, including vaccine approaches. Traditional, reductionist and hypothesis-driven research have provided important, yet isolated, insights into Campylobacter pathogenesis. Currently, strategies for detecting, preventing, controlling and eliminating Campylobacter transmission are lacking or inadequate. There is an urgent need for novel anti-Campylobacter intervention, due to increasing resistance of C. jejuni to available drugs. The main goal of this research project is to understand the mechanism of Campylobacter jejuni colonization and pathogenesis with respect to the identification of novel vaccine antigens using systems biology approaches. Objective 1 focuses on the mining of C. jejuni genomes and gene expression data to identify surface exposed proteins expressed under in vivo or in vivo mimicking conditions. Objective 2 consists in characterizing the surfaceome of C. jejuni using proteomic approaches. Colonization factors constitute ideal vaccine antigens since they are less likely to be subject to evolutionary changes. Therefore, objective 3 focuses on the integration of the data generated in objectives 1 and 2, and the identification of colonization factors. The results from the proposed studies will reveal new promising Campylobacter vaccine candidates for prevention of Campylobacter disease. In addition, it will generate new insights on the mechanism of C. jejuni interactions with its environment and its host. In turn, the gained knowledge could be translated by Variation Biotechnologies Inc. in commercialization of a Campylobacter vaccine.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
395380-2009
Name nom
Stintzi, Alain
Department département
Biochemistry, Microbiology and Immunology
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2009
Award amount
25000
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
1
Nb partie
1
Application title
Systems biology of campylobacter jejuni and vaccine development
Keyword
NA
Application summary
C. jejuni is the leading cause of bacterial gastroenteritis worldwide and thus constitutes a major public health threat. Despite this high incidence, a clear picture of the processes involved in Campylobacter infection has not yet emerged, preventing the development of new therapeutics and prevention strategies, including vaccine approaches. Traditional, reductionist and hypothesis-driven research have provided important, yet isolated, insights into Campylobacter pathogenesis. Currently, strategies for detecting, preventing, controlling and eliminating Campylobacter transmission are lacking or inadequate. There is an urgent need for novel anti-Campylobacter intervention, due to increasing resistance of C. jejuni to available drugs. The main goal of this research project is to understand the mechanism of Campylobacter jejuni colonization and pathogenesis with respect to the identification of novel vaccine antigens using systems biology approaches. Objective 1 focuses on the mining of C. jejuni genomes and gene expression data to identify surface exposed proteins expressed under in vivo or in vivo mimicking conditions. Objective 2 consists in characterizing the surfaceome of C. jejuni using proteomic approaches. Colonization factors constitute ideal vaccine antigens since they are less likely to be subject to evolutionary changes. Therefore, objective 3 focuses on the integration of the data generated in objectives 1 and 2, and the identification of colonization factors. The results from the proposed studies will reveal new promising Campylobacter vaccine candidates for prevention of Campylobacter disease. In addition, it will generate new insights on the mechanism of C. jejuni interactions with its environment and its host. In turn, the gained knowledge could be translated by Variation Biotechnologies Inc. in commercialization of a Campylobacter vaccine.